# Phase I trial of hydroxychloroquine with dose-intense temozolomide in patients with advanced solid tumors and melanoma

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/phase-i-trial-of-hydroxychloroquine-with-dose-intense-temozolomide-in-patients/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Reshma Rangwala,Robert D. Leone,Yunyoung C Chang,Leslie A. Fecher,Lynn M. Schuchter,Amy Kramer,Kay-See Tan,Daniel F. Heitjan,Glenda Rodgers,Maryann Gallagher,Shengfu Piao,Andrea B. Troxel,Tracey L. Evans,Angela DeMichele,Katherine L. Nathanson,Peter J. O’Dwyer,Jonathon Kaiser,Laura Pontiggia,Lisa E. Davis,Ravi K. Amaravadi |
| Citations | 369 |
| DOI | 10.4161/auto.29118 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://www.tandfonline.com/doi/pdf/10.4161/auto.29118?needAccess=true |
| OpenAlex ID | https://openalex.org/W2055510039 |
| PMID | 24991839 |
| Type | article |
| Year | 2014 |

## Paper authors

- [Leslie A. Fecher](https://scholariq.org/researchers/leslie-a-fecher/)

## Paper primary topic

- [Autophagy in Disease and Therapy](https://scholariq.org/topics/autophagy-in-disease-and-therapy/)

## Paper topics

- [Autophagy in Disease and Therapy](https://scholariq.org/topics/autophagy-in-disease-and-therapy/)
- [Histone Deacetylase Inhibitors Research](https://scholariq.org/topics/histone-deacetylase-inhibitors-research/)
- [Melanoma and MAPK Pathways](https://scholariq.org/topics/melanoma-and-mapk-pathways/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.